Back

Why should cardiopulmonary exercise testing be routinely used for assessing patients with valvular heart disease?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease Diagnostic Methods ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Cristina Cortina Camarero

University Hospital Infanta Leonor, Madrid (Spain)

9 More presentations in this session

Presentation thumbnail
Age distribution of valvular heart disease in China: from a national multicenter prospective cohort study
Doctor H. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Trends in rheumatic heart disease in Egypt (2006-2018): data from the national rheumatic heart prevention and control program
Doctor A. El Ghamrawy (Almahalla Alkobra, EG)
Abstract Slides
Presentation thumbnail
Survival of people with valvular heart disease in the community (OxValve-Survive)
Associate Professor S. Myerson (Oxford, GB)
Abstract Slides
Presentation thumbnail
Identification of microRNAs in aortic valve calcification patients with bicuspid aortic valve
Doctor Z. meng (Beijing, CN)
Abstract
Presentation thumbnail
Lipoprotein(a) and autotaxin in patients with stenotic atherosclerosis of coronary arteries and aortic valve stenosis
Mr M. Ezhov (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources